You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

List of Excipients in API dolutegravir sodium and rilpivirine hydrochloride

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing dolutegravir sodium and rilpivirine hydrochloride

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
ViiV Healthcare Company	JULUCA	dolutegravir sodium and rilpivirine hydrochloride	49702-242	CELLULOSE, MICROCRYSTALLINE	2031-01-24
ViiV Healthcare Company	JULUCA	dolutegravir sodium and rilpivirine hydrochloride	49702-242	CROSCARMELLOSE SODIUM	2031-01-24
ViiV Healthcare Company	JULUCA	dolutegravir sodium and rilpivirine hydrochloride	49702-242	LACTOSE MONOHYDRATE	2031-01-24
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for dolutegravir sodium and rilpivirine hydrochloride

Excipient focus: CELLULOSE, MICROCRYSTALLINE

dolutegravir sodium and rilpivirine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and rilpivirine hydrochloride	49702-242
>Company	>Ingredient	>NDC

dolutegravir sodium and rilpivirine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

dolutegravir sodium and rilpivirine hydrochloride drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and rilpivirine hydrochloride	49702-242
>Company	>Ingredient	>NDC

dolutegravir sodium and rilpivirine hydrochloride drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

dolutegravir sodium and rilpivirine hydrochloride drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and rilpivirine hydrochloride	49702-242
>Company	>Ingredient	>NDC

dolutegravir sodium and rilpivirine hydrochloride drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

dolutegravir sodium and rilpivirine hydrochloride drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and rilpivirine hydrochloride	49702-242
>Company	>Ingredient	>NDC

dolutegravir sodium and rilpivirine hydrochloride drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 20

dolutegravir sodium and rilpivirine hydrochloride drug variants containing POLYSORBATE 20

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and rilpivirine hydrochloride	49702-242
>Company	>Ingredient	>NDC

dolutegravir sodium and rilpivirine hydrochloride drug variants not containing POLYSORBATE 20

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE K30

dolutegravir sodium and rilpivirine hydrochloride drug variants containing POVIDONE K30

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and rilpivirine hydrochloride	49702-242
>Company	>Ingredient	>NDC

dolutegravir sodium and rilpivirine hydrochloride drug variants not containing POVIDONE K30

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

dolutegravir sodium and rilpivirine hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and rilpivirine hydrochloride	49702-242
>Company	>Ingredient	>NDC

dolutegravir sodium and rilpivirine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STEARYL FUMARATE

dolutegravir sodium and rilpivirine hydrochloride drug variants containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and rilpivirine hydrochloride	49702-242
>Company	>Ingredient	>NDC

dolutegravir sodium and rilpivirine hydrochloride drug variants not containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.